<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-26892" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Penicillin Allergy</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Patterson</surname>
            <given-names>Rachel A.</given-names>
          </name>
          <aff>St Lukes University Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Stankewicz</surname>
            <given-names>Holly A.</given-names>
          </name>
          <aff>St. Luke's University Health Network</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Rachel Patterson declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Holly Stankewicz declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>20</day>
          <month>6</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-26892.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Penicillin (PCN) was discovered by Alexander Flemming in 1928 and became widely used in 1942 to treat various staphylococcal and streptococcal bacterial infections. Today, penicillin is still one of the most widely prescribed antibiotics. Penicillin is also one of the most frequently reported medication allergies. The penicillin family of antibiotics includes penicillin derivatives of ampicillin and amoxicillin as well as cephalosporins, monobactams, carbapenems, and beta-lactamase inhibitors. All penicillins share the same core beta-lactam and thiazolidine ring structures but differ in their side chains. Identification of true penicillin allergy is critical as 80% to 90% of people once considered allergic are ultimately able to tolerate penicillins resulting in the decreased need for broad-spectrum antibiotics and development of multi-drug resistant organisms. This activity reviews the pathophysiology of penicillin allergy and highlights the role of the interprofessional team in the management of these patients.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the cause of penicillin allergy.</p></list-item><list-item><p>Review the pathophysiology of penicillin allergy.</p></list-item><list-item><p>Summarize the treatment of patients with penicillin allergy.</p></list-item><list-item><p>Describe interprofessional team strategies for improving care and outcomes in patients with penicillin allergy.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=26892&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=26892">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-26892.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Penicillin (PCN) was discovered by Alexander Flemming in 1928 and became widely used in 1942 to treat various staphylococcal<italic toggle="yes"> and </italic>streptococcal bacterial infections. Today, penicillin is still one of the most widely prescribed antibiotics. Penicillin is also one of the most frequently reported medication allergies. The penicillin family of antibiotics includes penicillin derivatives of ampicillin and amoxicillin as well as cephalosporins, monobactams, carbapenems, and beta-lactamase inhibitors. All penicillins share the same core beta-lactam and thiazolidine ring structures but differ in their side chains. Identification of true penicillin allergy is&#x000a0;critical as 80% to 90% of people once considered&#x000a0;allergic are ultimately able to tolerate penicillins resulting in the decreased need for broad-spectrum antibiotics and development of multi-drug resistant&#x000a0;organisms.<xref ref-type="bibr" rid="article-26892.r1">[1]</xref><xref ref-type="bibr" rid="article-26892.r2">[2]</xref><xref ref-type="bibr" rid="article-26892.r3">[3]</xref><xref ref-type="bibr" rid="article-26892.r4">[4]</xref></p>
      </sec>
      <sec id="article-26892.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Penicillin is a beta-lactam antibiotic. Included in the penicillin family of antibiotics are penicillin G, penicillin V, procaine penicillin, benzathine penicillin as well as over 15 related compounds with broader antibacterial effects. Type 1&#x000a0;and type 4 hypersensitivity reactions&#x000a0;mediate the most common allergies to penicillin. Serious allergic reactions to penicillin are Type 1 and mediated by IgE. Risk factors for IgE mediated reactions include high-dose parenteral administration and repetitive or frequent dosing of penicillins. Most severe reactions occur between the ages of 20 to 49 years. Previously, PCN related antibiotics such as cephalosporins were avoided given concern for cross-reactivity. Current research suggests that similarities between the chemical structures of the R-side chains are&#x000a0;what determines cross-reactivity between classes of penicillin-related compounds, enabling greater use of antibiotics previously avoided. Of note, amoxicillin is the most common of the penicillins associated with cross-reactivity.<xref ref-type="bibr" rid="article-26892.r5">[5]</xref><xref ref-type="bibr" rid="article-26892.r6">[6]</xref></p>
      </sec>
      <sec id="article-26892.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Approximately 10% of patients report an allergy to penicillin however&#x000a0;up to 90% of these patients do not have a true allergy. The incidence of anaphylaxis&#x000a0;to penicillin is 0.02% to 0.04% and is mediated by a type 1 hypersensitivity reaction. Overall, cutaneous eruptions are the most commonly reported reaction. IgE antibodies decrease over time. In patients who have previously tested positive for penicillin allergy, there is an expected 10% decrease/year of a subsequent positive reaction. Therefore, with the avoidance of PCN, 80% to 100% of patients will ultimately test&#x000a0;negative for penicillin allergy&#x000a0;10 years after the initial positive test. The presence of an underlying bacterial or viral infection with penicillin administration also often resulted in false reporting of penicillin&#x000a0;allergies such as the exanthem seen with EBV.</p>
        <p>Cross-reactivity with other penicillin-related compounds, specifically&#x000a0;cephalosporins, has resulted in the avoidance of drug use. Early studies may have also over-estimated cross-reactivity between penicillin and cephalosporins as the production of early generation cephalosporins may have been contaminated with small amounts of penicillin. Penicillin has a single R side chain whereas cephalosporins have two. If the penicillin side chain is similar to either cephalosporin side chain, there is a greater risk of cross-reactivity. This more commonly occurs with first and second generation cephalosporins than with third or fourth generation cephalosporins making the latter more attractive treatment choices when a patient has a proven penicillin allergy. Overall, cross-reactivity with aminopenicillins is less than 2%, carbapenems less than 1% and cephalosporins less than 3%. There is no significant reported cross-reactivity with monobactams.</p>
      </sec>
      <sec id="article-26892.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>All penicillins share the same core beta-lactam and thiazolidine ring structures but differ in their side chains. The ring structure is metabolized into major (penicilloyl) and minor (penicillin, penicilloate, and penilloate) antigenic determinates. Immediate reactions are the result of IgE that cross-like on mast cells when exposed to the antigenic component. The result is degranulation and release of histamine as well as other vasoactive substances. It is the minor antigenic determinates that generate IgE specific responses that are associated with true penicillin allergy. These minor determinates result in immediate reactions, within minutes to 1 hour, and characterized by signs and symptoms of acute anaphylaxis such as urticaria, flushing, dyspnea, bronchospasm with wheezing, angioedema, hypotension, tachycardia, mental status change or gastrointestinal (GI) upset. The major antigenic determinates&#x000a0;more commonly&#x000a0;are associated with less severe urticarial&#x000a0;reactions.</p>
        <p>Delayed reactions are mediated by IgM and IgG which activates the complement system resulting in inflammatory reactions that include Type 2 to 4 hypersensitivity reactions. Serious hypersensitivity reactions include hemolytic anemia, toxic epidermal necrolysis (TEN), Steven's Johnson Syndrome (SJS), vasculitis, interstitial&#x000a0;nephritis, serum sickness, thrombocytopenia, and neutropenia.</p>
      </sec>
      <sec id="article-26892.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>For patients presenting with an acute allergic reaction after administration of penicillin, it is important to determine when the medication was given, route of administration, as well as onset and type of symptoms including respiratory difficulty, GI symptoms, mental status changes, and cardiovascular collapse such as hypotension or skin findings. For those patients who report a history of penicillin allergy due to previous exposure, onset and timing are again important as is route&#x000a0;and ability to tolerate other beta-lactams&#x000a0;previously. Other important historical questions include how the penicillin allergy was managed. For example, if the patient was treated with antihistamines or epinephrine and had improvement/resolution of symptoms, this is supportive of an IgE reaction and a true penicillin allergy.</p>
        <p>For patients presenting with an acute allergic reaction to penicillin, the initial exam should always focus on airway, breathing, and circulation. The patient should&#x000a0;quickly and carefully&#x000a0;be examined for edema of the lips, tongue or oropharynx and any difficulty swallowing or handling his/her secretions. Heart and lungs should be carefully auscultated&#x000a0;as well for arrhythmia, and adventitious breath sounds such as wheezing or stridor. Confusion and abdominal pain are also findings of severe anaphylaxis. Cutaneous symptoms are often the first and most common finding of an allergic reaction, however, are absent in 10% to 20% of patients experiencing an allergic reaction. Common cutaneous symptoms are generalized urticaria, flushing, pruritis, and angioedema.&#x000a0;</p>
      </sec>
      <sec id="article-26892.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>To determine if a patient has an IgE mediated penicillin allergy, the only validated test currently available in the united states is penicillin skin testing. A board-certified allergist should perform the test. It involves a skin-prick with the application of the major and minor determinants as well as a control. The area of skin is examined 15 minutes later. If a wheel&#x000a0;of at least 3 mm and concomitant&#x000a0;erythema develop, the test is positive. The test should not be performed if the reaction to penicillin was a severe non-IgE mediated reaction.<xref ref-type="bibr" rid="article-26892.r7">[7]</xref><xref ref-type="bibr" rid="article-26892.r8">[8]</xref><xref ref-type="bibr" rid="article-26892.r9">[9]</xref><xref ref-type="bibr" rid="article-26892.r10">[10]</xref></p>
        <p>If skin testing is negative, intra-dermal testing can then also be performed using the same antigenic determinants. Just as with skin testing, a positive intradermal test is characterized by the development&#x000a0;of a 3 mm or more wheal&#x000a0;and erythema at the site of injection. Readings are taken at 15 min for a history of immediate reaction and at 48 and 72 hours with a history of delayed reaction. &#x000a0;Patients may need to wait up to 6 weeks after initial testing before undergoing intra-dermal testing.</p>
        <p>A&#x000a0;graded-dose challenge can also be performed when skin testing is negative. Here the patients receive anywhere from 1/100, if initial reaction was anaphylactic, to 1/10 of a dose with progressively increasing doses after that. After each dose administration, the patient has a 30 to 60 minute observation period. If no reaction occurs, the patients then receive a full dose, again followed by a period of observation. Testing must be performed by a board-certified allergist and should be performed at least 4 to 6 weeks after an acute reaction, use of steroids or anti-histamines or any signs of asthma or urticaria. The graded-dose challenge is also contraindicated if the initial reaction was a severe non-IgE mediated reaction such as Stevens-Johnson syndrome (SJS) or toxic epidermal necrolysis (TEN).</p>
      </sec>
      <sec id="article-26892.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treatment for acute IgE mediated reaction to penicillin depends on severity. Patients presenting in acute anaphylaxis need to have immediate treatment with IM epinephrine (1 mg/ml) 0.3 mg to 0.5 mg every 5 to 15 minutes until resolution of symptoms. Adjunctive therapies include H1 and H2 antihistamines including diphenhydramine 25 mg to 50 mg intravenously (IV) and ranitidine 50 mg IV, respectively. Glucocorticoids should also be administered such as 125 mg methylprednisone. Patients with refractory symptoms should be treated with an infusion of epinephrine at 0.1 mcg/kg/minute. All patients presenting with acute anaphylaxis should be immediately placed on telemetry monitoring with large-bore IV for IVF resuscitation at 1 L to 2 L NS bolus. If patients are experiencing bronchospasm, albuterol 2.5 mg to 5 mg can also be considered. These patients require admission to the hospital. Patients with a resolution of symptoms after a period of observation are safe for discharge.&#x000a0;<xref ref-type="bibr" rid="article-26892.r11">[11]</xref><xref ref-type="bibr" rid="article-26892.r12">[12]</xref><xref ref-type="bibr" rid="article-26892.r13">[13]</xref></p>
        <p>For those patients presenting with mild reactions and have cutaneous findings only, treatment with an antihistamine such as diphenhydramine is adequate.</p>
        <p>For patients with a true Type 1 IgE mediated penicillin allergy, another antibiotic should be used for treatment. If there is not another equally as efficacious antibiotic, patient's should undergo drug desensitization. The process of desensitization involves&#x000a0;subcutaneous, intravenous, or oral&#x000a0;administration of incrementally higher doses of the drug every 15 to 30 minutes until the patient tolerates the entire dose.&#x000a0;For patients with histories of severe IgE mediated reactions, initial doses should be between 1/1,000,000 and 1/10,000 of the full therapeutic dose. Success rates for desensitization&#x000a0;can reach up to 100%. Drug desensitization is again contraindicated in patients with severe non-IgE-mediated reactions such as SJS or TEN.</p>
      </sec>
      <sec id="article-26892.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>Acute urticaria</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Allergic contact dermatitis</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Chronic urticaria</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Erythema multiforme</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Erythema nodosum</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Erythroderma</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Hypersensitivity vasculitis</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Irritant contact dermatitis</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Lichen planus&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Sweet syndrome</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-26892.s10" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Identification of patients with a true, IgE mediated penicillin allergy is of vital importance to help improve&#x000a0;antibiotic utilization with decrease usage of broad-spectrum antibiotics as well as slow the spread of multi-drug resistant&#x000a0;bacteria. Other effects include overall decreased health care costs with decreased length of hospitalization as well as decreased readmission rate due to antibiotic failure.</p>
      </sec>
      <sec id="article-26892.s11" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>All healthcare workers including the nurse practitioner and pharmacist who prescribe/dispense penicillin must ask the patient if he or she is allergic to the medication, as part of an interprofessional team approach to patient care. Penicillin allergy can be serious and result in a life-threatening anaphylactic reaction. Patients should be asked to wear an ID bracelet about their medical health problems, including allergies. The healthcare workers must ask for allergies at each and every admission because, in the complex world of medicine, some data are omitted or forgotten and lead to serious consequences. Pharmacists should check the patient medication record, checking for agents that may have crossover allergic reaction, and assess the safety of cephalosporins in conjunction with the prescriber. Nursing staff should be vigilant on the intake so that this mistake is never made, but also should have the patient clarify any prior allergic reaction to penicillin drugs. These interprofessional steps can prevent penicillin allergy and prevention is the optimal management strategy. [Level 5]<xref ref-type="bibr" rid="article-26892.r8">[8]</xref><xref ref-type="bibr" rid="article-26892.r14">[14]</xref><xref ref-type="bibr" rid="article-26892.r15">[15]</xref></p>
      </sec>
      <sec id="article-26892.s12">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=26892&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=26892">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/allergy/penicillin-allergy/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=26892">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/26892/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=26892">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-26892.s13">
        <title>References</title>
        <ref id="article-26892.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Salvadori</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Audino</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Venturi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Garo</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Salgarello</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Antibiotic prescribing for endodontic infections: a survey of dental students in Italy.</article-title>
            <source>Int Endod J</source>
            <year>2019</year>
            <month>Sep</month>
            <volume>52</volume>
            <issue>9</issue>
            <fpage>1388</fpage>
            <page-range>1388-1396</page-range>
            <pub-id pub-id-type="pmid">30982994</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26892.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Blumenthal</surname>
                <given-names>KG</given-names>
              </name>
              <name>
                <surname>Huebner</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Fu</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Bhattacharya</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Levin</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Mancini</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Slawski</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Banerji</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Risk-based pathway for outpatient penicillin allergy evaluations.</article-title>
            <source>J Allergy Clin Immunol Pract</source>
            <year>2019</year>
            <season>Sep-Oct</season>
            <volume>7</volume>
            <issue>7</issue>
            <fpage>2411</fpage>
            <page-range>2411-2414.e1</page-range>
            <pub-id pub-id-type="pmid">30981747</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26892.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kleris</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Tang</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Radojicic</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lugar</surname>
                <given-names>PL</given-names>
              </name>
            </person-group>
            <article-title>Pricking away at penicillin allergy with a dedicated outpatient clinic.</article-title>
            <source>J Allergy Clin Immunol Pract</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>7</volume>
            <issue>4</issue>
            <fpage>1358</fpage>
            <page-range>1358-1359.e1</page-range>
            <pub-id pub-id-type="pmid">30967194</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26892.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abrams</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Ben-Shoshan</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Delabeling penicillin allergy: Is skin testing required at all?</article-title>
            <source>J Allergy Clin Immunol Pract</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>7</volume>
            <issue>4</issue>
            <fpage>1377</fpage>
            <pub-id pub-id-type="pmid">30961847</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26892.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Taremi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Artau</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Foolad</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Berlin</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>White</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Raad</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Adachi</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Safety, Efficacy, and Clinical Impact of Penicillin Skin Testing in Immunocompromised Cancer Patients.</article-title>
            <source>J Allergy Clin Immunol Pract</source>
            <year>2019</year>
            <season>Sep-Oct</season>
            <volume>7</volume>
            <issue>7</issue>
            <fpage>2185</fpage>
            <page-range>2185-2191.e1</page-range>
            <pub-id pub-id-type="pmid">30928660</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26892.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marchitto</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Petrone</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gradon</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Almost Killed by Love: A Cautionary Coital Tale.</article-title>
            <source>Am J Med</source>
            <year>2019</year>
            <month>Aug</month>
            <volume>132</volume>
            <issue>8</issue>
            <fpage>e650</fpage>
            <page-range>e650-e651</page-range>
            <pub-id pub-id-type="pmid">30928347</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26892.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Savic</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Kopac</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Clarke</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Cooke</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Dewachter</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ebo</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Garcez</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Garvey</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Guttormsen</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Hopkins</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Hepner</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Kolawole</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kr&#x000f8;igaard</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Laguna</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Marshall</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Mertes</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Platt</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Rose</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Sabato</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Sadleir</surname>
                <given-names>PHM</given-names>
              </name>
              <name>
                <surname>Savic</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Takazawa</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Voltolini</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Volcheck</surname>
                <given-names>GW</given-names>
              </name>
            </person-group>
            <article-title>Management of a surgical patient with a label of penicillin allergy: narrative review and consensus recommendations.</article-title>
            <source>Br J Anaesth</source>
            <year>2019</year>
            <month>Jul</month>
            <volume>123</volume>
            <issue>1</issue>
            <fpage>e82</fpage>
            <page-range>e82-e94</page-range>
            <pub-id pub-id-type="pmid">30916014</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26892.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Blumenthal</surname>
                <given-names>KG</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Hsu</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Wolfson</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Berkowitz</surname>
                <given-names>DN</given-names>
              </name>
              <name>
                <surname>Carballo</surname>
                <given-names>VA</given-names>
              </name>
              <name>
                <surname>Schwartz</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Marquis</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Elshaboury</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gandhi</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Lambl</surname>
                <given-names>BB</given-names>
              </name>
              <name>
                <surname>Freeley</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Gruszecki</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wickner</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Shenoy</surname>
                <given-names>ES</given-names>
              </name>
            </person-group>
            <article-title>Outcomes from an inpatient beta-lactam allergy guideline across a large US health system.</article-title>
            <source>Infect Control Hosp Epidemiol</source>
            <year>2019</year>
            <month>May</month>
            <volume>40</volume>
            <issue>5</issue>
            <fpage>528</fpage>
            <page-range>528-535</page-range>
            <pub-id pub-id-type="pmid">30915929</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26892.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Banks</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Tucker</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Macy</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Evaluating Penicillin Allergies Without Skin Testing.</article-title>
            <source>Curr Allergy Asthma Rep</source>
            <year>2019</year>
            <month>Mar</month>
            <day>22</day>
            <volume>19</volume>
            <issue>5</issue>
            <fpage>27</fpage>
            <pub-id pub-id-type="pmid">30903298</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26892.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kleris</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Lugar</surname>
                <given-names>PL</given-names>
              </name>
            </person-group>
            <article-title>Things We Do For No Reason&#x02122;: Failing to Question a Penicillin Allergy History.</article-title>
            <source>J Hosp Med</source>
            <year>2019</year>
            <month>Nov</month>
            <volume>14</volume>
            <issue>11</issue>
            <fpage>704</fpage>
            <page-range>704-706</page-range>
            <pub-id pub-id-type="pmid">30897049</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26892.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rosenberg</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Evaluate Penicillin Allergy Before Deciding Against Penicillin Use.</article-title>
            <source>Am J Nurs</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>119</volume>
            <issue>4</issue>
            <fpage>63</fpage>
            <page-range>63-64</page-range>
            <pub-id pub-id-type="pmid">30896497</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26892.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Collins</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Choe</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mochizuki</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Cannavino</surname>
                <given-names>CR</given-names>
              </name>
            </person-group>
            <article-title>Evaluating penicillin allergies in children using a standard EMR-based questionnaire.</article-title>
            <source>Ann Allergy Asthma Immunol</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>122</volume>
            <issue>6</issue>
            <fpage>663</fpage>
            <page-range>663-665</page-range>
            <pub-id pub-id-type="pmid">30878624</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26892.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wanat</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Anthierens</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Butler</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Savic</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Savic</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pavitt</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Sandoe</surname>
                <given-names>JAT</given-names>
              </name>
              <name>
                <surname>Tonkin-Crine</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Patient and Primary Care Physician Perceptions of Penicillin Allergy Testing and Subsequent Use of Penicillin-Containing Antibiotics: A Qualitative Study.</article-title>
            <source>J Allergy Clin Immunol Pract</source>
            <year>2019</year>
            <season>Jul-Aug</season>
            <volume>7</volume>
            <issue>6</issue>
            <fpage>1888</fpage>
            <page-range>1888-1893.e1</page-range>
            <pub-id pub-id-type="pmid">30877074</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26892.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Torres</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Adkinson</surname>
                <given-names>NF</given-names>
              </name>
              <name>
                <surname>Caubet</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Kidon</surname>
                <given-names>MI</given-names>
              </name>
              <name>
                <surname>Mendelson</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Gomes</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Rerkpattanapipat</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Macy</surname>
                <given-names>E</given-names>
              </name>
              <collab>AAAAI/WAO 2018 Symposium Penicillin and Cephalosporin Allergy Testing Working Group</collab>
            </person-group>
            <article-title>Controversies in Drug Allergy: Beta-Lactam Hypersensitivity Testing.</article-title>
            <source>J Allergy Clin Immunol Pract</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>7</volume>
            <issue>1</issue>
            <fpage>40</fpage>
            <page-range>40-45</page-range>
            <pub-id pub-id-type="pmid">30245291</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26892.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moreno</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Laffond</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mu&#x000f1;oz-Bellido</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Gracia</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Mac&#x000ed;as</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>D&#x000e1;vila</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Using &#x003b2;-lactam antibiotics in patients with a history of &#x003b2;-lactam allergy: current concepts.</article-title>
            <source>Pol Arch Intern Med</source>
            <year>2017</year>
            <month>Aug</month>
            <day>09</day>
            <volume>127</volume>
            <issue>7-8</issue>
            <fpage>540</fpage>
            <page-range>540-549</page-range>
            <pub-id pub-id-type="pmid">28724882</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
